Patents Assigned to Taigen Biotechnology Co., Ltd.
  • HCV PROTEASE INHIBITORS
    Publication number: 20090286814
    Abstract: This invention relates to macrocyclic compounds of formula (I) or (II) shown in the specification. These compounds can be used to treat hepatitis C virus infection.
    Type: Application
    Filed: November 4, 2008
    Publication date: November 19, 2009
    Applicant: TaiGen Biotechnology Co., Ltd.
    Inventors: Chu-chung Lin, Kuang-Yuan Lee, Yo-chin Liu, Pin Lo, Rong-Jiunn Chen, Chen-Fu Liu, Chih-Ming Chen, Chi-Hsin Richard King
  • Heterocyclic Compounds
    Publication number: 20090264339
    Abstract: This invention relates to heterocyclic compounds of the formulas shown in the specification. It also relates to methods for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, and tissue injuries with one of the heterocyclic compounds.
    Type: Application
    Filed: November 3, 2008
    Publication date: October 22, 2009
    Applicant: TaiGen Biotechnology Co., Ltd.
    Inventors: Chi-Feng Yen, Cheng-Kung Hu, Chang-Pin Huang, Ying-Huey Huang, Gholam Hossein Hakimelahi, Chi-Hsin Richard King
  • KINESIN INHIBITORS
    Publication number: 20090214529
    Abstract: This invention relates to the compounds of formula (I) shown below. Each variable in formula (I) is defined in the specification. These compounds can be used to treat a kinesin Eg5 protein-mediated disorder.
    Type: Application
    Filed: May 22, 2008
    Publication date: August 27, 2009
    Applicant: TaiGen Biotechnology Co., Ltd.
    Inventors: Ching-Cheng Wang, Hung-Chuan Chen, Shu-Huei Wang, Mei-Chun Lin, Tien-Lan Shieh, Ying-Huey Huang, Shih-Chieh Chuang, Chi-Hsin Richard King
  • PYRIMIDINE COMPOUNDS
    Publication number: 20090143302
    Abstract: This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject in need thereof an effective amount of one or more compounds of formula (I). Each variable in this formula is defined in the specification.
    Type: Application
    Filed: December 8, 2008
    Publication date: June 4, 2009
    Applicant: TaiGen Biotechnology Co., Ltd.
    Inventors: Chi-Feng Yen, Cheng-Kung Hu, Ming-Chen Chou, Chen-Tso Tseng, Chien-Huang Wu, Ying-Huey Huang, Shu-Jen Chen, Chi-Hsin Richard King
  • HCV PROTEASE INHIBITORS
    Publication number: 20090111757
    Abstract: Compounds of formula (I): in which R1, R2, R3 R4, and R5, U, X, Y, and Z are as defined herein. Also disclosed is use of these compounds, alone or in combination with other active agents, to treat hepatitis C virus infection.
    Type: Application
    Filed: October 20, 2008
    Publication date: April 30, 2009
    Applicant: TaiGen Biotechnology Co., Ltd.
    Inventors: Chu-Chung Lin, Kuang-Yuan Lee, Chen-Fu Liu, Pin Lo, Yo-Chin Liu, Yueh-chiang Han, Chi-Hsin Richard King
  • Polyamine compounds
    Patent number: 7504422
    Abstract: This invention relates to methods for treating retinopathy and repairing tissue damage. The methods include administering to a subject in need thereof an effective amount of one or more compounds of the following formula. Each variable in this formula is defined in the specification.
    Type: Grant
    Filed: August 6, 2007
    Date of Patent: March 17, 2009
    Assignee: Taigen Biotechnology Co. Ltd.
    Inventors: Chi-Feng Yen, Chi-Hsin Richard King, Hua-Chien Chen, Gholam Hossein Hakimelahi, Shu-Jen Chen, Ying-Huey Huang, Chien-Huang Wu
  • Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases
    Patent number: 7462594
    Abstract: This invention relates to treating an infection with a virus using protease inhibitors. Examples of the protease inhibitors include compounds of formula (II). Each variable is defined in the specification.
    Type: Grant
    Filed: February 25, 2005
    Date of Patent: December 9, 2008
    Assignee: Taigen Biotechnology Co., Ltd.
    Inventors: Syaulan Yang, Jen-Dar Wu, Feng-Yih Su, Chun-Wei Kuo, Wen-Chang Chen, Ming-Chu Hsu, Yibin Xiang, Ching-Cheng Wang, Shao-Ying Liao
  • KINESIN INHIBITORS
    Publication number: 20080292626
    Abstract: This invention relates to the compounds of formula (I) shown below. Each variable in formula (I) is defined in the specification. These compounds can be used to treat a kinesin Eg5 protein-mediated disorder.
    Type: Application
    Filed: May 22, 2008
    Publication date: November 27, 2008
    Applicant: TaiGen Biotechnology Co., Ltd.
    Inventors: Ching-Cheng Wang, Hung-Chuan Chen, Shu-Huei Wang, Mei-Chun Lin, Tien-Lan Shieh, Ying-Huey Huang, Shih-Chieh Chuang, Chi-Hsin Richard King
  • PROTEASE INHIBITORS
    Publication number: 20080125375
    Abstract: This invention relates to treating an infection with a virus using protease inhibitors. Examples of the protease inhibitors include compounds of formula (I). Each variable is defined in the specification.
    Type: Application
    Filed: December 3, 2007
    Publication date: May 29, 2008
    Applicant: TaiGen Biotechnology Co., Ltd.
    Inventors: Syaulan Yang, Jen-Dar Wu, Feng-Yih Su, Chun-Wei Kuo, Wen-Chang Chen, Yibin Xiang, Ching-Cheng Wang, Shao-Ying Liao
  • Aminoquinoline compounds
    Patent number: 7378524
    Abstract: This invention relates to treating inflammatory and immune diseases with certain aminoquinoline compounds that bind to CXCR3 receptors. The aminoquinoline compounds are covered by the formula (I) shown below. Each variable is defined in the specification.
    Type: Grant
    Filed: September 29, 2004
    Date of Patent: May 27, 2008
    Assignee: Taigen Biotechnology Co., Ltd.
    Inventors: Chu-Chung Lin, Jen-Fuh Liu, Chih-Wei Chang, Shu-Jen Chen, Yibin Xiang, Pei-Chin Cheng, Jiing-Jyh Jan
  • HCV PROTEASE INHIBITORS
    Publication number: 20080108632
    Abstract: This invention relates to the compounds of formula (I) shown below. Each variable in formula (I) is defined in the specification. These compounds can be used to treat hepatitis C virus infection.
    Type: Application
    Filed: November 2, 2007
    Publication date: May 8, 2008
    Applicant: TaiGen Biotechnology Co., Ltd.
    Inventors: Chu-chung Lin, Pei-chin Cheng, Yo-chin Liu, Chen-fu Liu, Chi-Hsin Richard King
  • POLYAMINE COMPOUNDS
    Publication number: 20080058382
    Abstract: This invention relates to methods for treating retinopathy and repairing tissue damage. The methods include administering to a subject in need thereof an effective amount of one or more compounds of the following formula. Each variable in this formula is defined in the specification.
    Type: Application
    Filed: August 6, 2007
    Publication date: March 6, 2008
    Applicant: TaiGen Biotechnology Co., Ltd.
    Inventors: Chi-Feng Yen, Chi-Hsin King, Hua-Chien Chen, Gholam Hakimelahi, Shu-Jen Chen, Ying-Huey Huang, Chien-Huang Wu